Back
Prenetics Global Vs. Monopar Therapeutics Industry Stock Comparison
Sell
25
PRE
Prenetics Global
Last Price:
$4.05
Seasonality Move:
-5.51%
Sell
46
MNPR
Monopar Therapeutics
Last Price:
$37.99
Seasonality Move:
-13.48%
Sell
25
Prenetics Global (PRE)
is a Sell
Is Prenetics Global a Buy, Sell or Hold?
-
The current Prenetics Global [PRE] share price is $4.09. The Score for PRE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
PRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.60. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRE Stock Price Chart
What is Prenetics Global's stock price today?
-
The Prenetics Global share price today is $4.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRE is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.60The current trend is moderately bullish and MNPR is experiencing slight selling pressure.
PRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 28.51 | Sell |
Chaikin Money Flow: | -500 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.35 - 5.21) | Sell |
Bollinger Bands (100): | (4.52 - 5.6) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 53.16 | Buy |
Chaikin Money Flow: | -4864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.9 - 41.16) | Buy |
Bollinger Bands (100): | (18.89 - 38.95) | Buy |
PRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.29 | Sell |
20-day SMA: | 4.64 | Sell |
50-day SMA: | 5.15 | Sell |
200-day SMA: | 5.16 | Sell |
8-day EMA: | 4.28 | Sell |
20-day EMA: | 4.58 | Sell |
50-day EMA: | 4.92 | Sell |
200-day EMA: | 5.45 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.16 | Buy |
20-day SMA: | 33.55 | Buy |
50-day SMA: | 36.72 | Buy |
200-day SMA: | 16.35 | Buy |
8-day EMA: | 37.12 | Buy |
20-day EMA: | 35.96 | Buy |
50-day EMA: | 34.41 | Buy |
200-day EMA: | 21.02 | Buy |
Prenetics Global Earnings Growth & PRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Prenetics Global Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |